Hope on the Horizon: Vera Therapeutics Charts a Course Through Critical Clinical Milestones
Aurinia Finds Its Rhythm: Strong Q3 Results Spark Investor Enthusiasm
Aurinia Pharma Stands Firm: Lupus Drug Lupkynis Defies FDA Post-Scandal Amidst Market Jolt
Unveiling the Shadowy Ethics: Former Pharma CEO's FDA Claims Spark Regulatory Outcry